| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |